<DOC>
	<DOC>NCT02348333</DOC>
	<brief_summary>The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of 7-day-repeated doses of FYU-981 administered orally to healthy male adults once daily. Participants are randomized to placebo (n=3) or FYU-981 (n=6) in each step. After follow-up examination in the step of lower dose, the next dose is administered.</brief_summary>
	<brief_title>Repeated Dose Phase I Study of FYU-981</brief_title>
	<detailed_description />
	<criteria>Japanese healthy adult subjects Body mass index: &gt;=18.5 and &lt;25.0 Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>